AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11967719 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline load (2 litres over 4 hours) followed by low salt intake (20 mmol) and furosemide administration
Number of subjects: 29
Study 11967719 — intervention group
Group type: COMPARATOR
Intervention: Dietary salt intake (high 260 mmol/day)
Number of subjects: 29
Study 10511450 — intervention group
Group type: EXPERIMENTAL
Intervention: Verb generation in L1 (Mandarin)
Number of subjects: 7
Study 10511450 — intervention group
Group type: EXPERIMENTAL
Intervention: Verb generation in L2 (English)
Number of subjects: 7
Study 10511450 — intervention group
Group type: COMPARATOR
Intervention: Comparison of verb generation vs word repetition in L1 and L2
Number of subjects: 7
Study 10511450 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-subject analysis of verb generation minus word repetition
Number of subjects: 7
Study 10511450 — intervention group
Group type: COMPARATOR
Intervention: Comparison of differences in frontal peaks
Number of subjects: 7
Study 7554754 — intervention group
Group type: COMPARATOR
Intervention: No fluid ingestion (trial A)
Number of subjects: 12
Study 7554754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 8% maltodextrin solution (trial B)
Number of subjects: 12
Study 2111658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin 7.5 mg/kg
Number of subjects: 6
Study 2111658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin 15 mg/kg
Number of subjects: 6
Study 2111658 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 6
Study 6115853 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 976
Study 6115853 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 976
Study 6115853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 976
Study 30887717 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle block with 8-10 mL of 0.25% bupivacaine before surgery (Group N)
Number of subjects: 75
Study 30887717 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-incisional infiltration with 0.25% bupivacaine preoperatively (Group P)
Number of subjects: 75
Study 30887717 — intervention group
Group type: COMPARATOR
Intervention: No regional analgesic pretreatment (Group C)
Number of subjects: 75
Study 27737326 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D and calcium supplementation, sedentary (CDG, n = 33)
Number of subjects: 104
Study 27737326 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation with aquatic exercises (DTG, n = 54)
Number of subjects: 104
Study 27737326 — intervention group
Group type: COMPARATOR
Intervention: Control group lacking vitamin D and calcium supplementation, sedentary (CG, n = 17)
Number of subjects: 104
Study 27686347 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 128
Study 27686347 — intervention group
Group type: COMPARATOR
Intervention: PSV
Number of subjects: 128
Study 24374798 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release tablet (IRT)
Number of subjects: 47
Study 24374798 — intervention group
Group type: COMPARATOR
Intervention: Food (fed condition)
Number of subjects: 47
Study 24374798 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole co-administration
Number of subjects: 47
Study 20953877 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution therapy using automated erythrocytapheresis
Number of subjects: 61
Study 20953877 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hemodilution therapy)
Number of subjects: 61
Study 19491388 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamins C and E, beta-carotene, zinc, and selenium) at nutritional doses
Number of subjects: 5220
Study 19491388 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum beta-carotene concentrations
Number of subjects: 5220
Study 19491388 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum vitamin C concentrations
Number of subjects: 5220
Study 19491388 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum zinc concentrations
Number of subjects: 5220
Study 17083283 — intervention group
Group type: EXPERIMENTAL
Intervention: MTV-style video clips (with jump cuts)
Number of subjects: 0
Study 17083283 — intervention group
Group type: COMPARATOR
Intervention: Continuous video clips
Number of subjects: 0
Study 15016557 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 26
Study 15016557 — intervention group
Group type: COMPARATOR
Intervention: Travoprost 0.004%
Number of subjects: 26
Study 11706771 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program on postoperative pain management
Number of subjects: 787
Study 11706771 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 787
Study 9022540 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (walking for 90 min at 60% of maximal oxygen uptake)
Number of subjects: 22
Study 9022540 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 22
Study 7954482 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide 300 mg daily (increased to 400 mg if necessary)
Number of subjects: 130
Study 7954482 — intervention group
Group type: COMPARATOR
Intervention: maprotiline 75 mg daily (increased to 100 mg if necessary)
Number of subjects: 130
Study 2959439 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar granules (5 g) sprinkled over food for 4 weeks
Number of subjects: 18
Study 29864548 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco and physical activity intervention including motivational counseling, behavior change plan, and nicotine replacement therapy
Number of subjects: 300
Study 29864548 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence and heart-healthy AN diet intervention including motivational counseling, behavior change plan, and medication bag
Number of subjects: 300
Study 29864548 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Group 1 and Group 2)
Number of subjects: 300
Study 27410244 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal cognitive task
Number of subjects: 0
Study 27410244 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cognitive task
Number of subjects: 0
Study 27410244 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor task
Number of subjects: 0
Study 27410244 — intervention group
Group type: COMPARATOR
Intervention: Control (no prior task)
Number of subjects: 0
Study 24240354 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide‐preserved multipurpose solution
Number of subjects: 218
Study 24240354 — intervention group
Group type: COMPARATOR
Intervention: One‐step peroxide disinfection system
Number of subjects: 218
Study 24240354 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lens care groups combined
Number of subjects: 218
Study 24240354 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of bacterial bioburden on lid margins
Number of subjects: 218
Study 22790678 — intervention group
Group type: EXPERIMENTAL
Intervention: 40,000 IU vitamin D(3) per week for 6 months
Number of subjects: 230
Study 22790678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 21635279 — intervention group
Group type: EXPERIMENTAL
Intervention: Root surface polishing (test sites)
Number of subjects: 10
Study 21635279 — intervention group
Group type: COMPARATOR
Intervention: Root planing (control sites)
Number of subjects: 10
Study 18573649 — intervention group
Group type: EXPERIMENTAL
Intervention: Current asthma symptoms assessment
Number of subjects: 119
Study 18573649 — intervention group
Group type: EXPERIMENTAL
Intervention: Controller medication usage
Number of subjects: 119
Study 17044205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer agreement
Number of subjects: 377
Study 17044205 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall agreement
Number of subjects: 377
Study 14551773 — intervention group
Group type: EXPERIMENTAL
Intervention: r-HuEPO treatment
Number of subjects: 16
Study 14551773 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study 10936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 1073
Study 10936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin combined with low, ineffective doses of warfarin
Number of subjects: 1073
Study 10936477 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk categorization by stratification schemes
Number of subjects: 1073
Study 10936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients >75 years old classified as high risk
Number of subjects: 1073
Study 10936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients >75 years old classified as low risk by one scheme
Number of subjects: 1073
Study 8716524 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal cannula oxygen delivery
Number of subjects: 11
Study 8716524 — intervention group
Group type: COMPARATOR
Intervention: Nasopharyngeal catheter oxygen delivery
Number of subjects: 11
Study 8716524 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods at 0.5 liters per minute
Number of subjects: 11
Study 1579136 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 129
Study 1579136 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ligation
Number of subjects: 129
Study 3901790 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE/H5,000 (0.5 mg dihydroergotamine plus 5,000 IU heparin)
Number of subjects: 880
Study 3901790 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE/H2,500 (0.5 mg dihydroergotamine plus 2,500 IU heparin)
Number of subjects: 880
Study 3901790 — intervention group
Group type: EXPERIMENTAL
Intervention: H5,000 (5,000 IU heparin alone)
Number of subjects: 880
Study 3901790 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE (0.5 mg dihydroergotamine alone)
Number of subjects: 880
Study 3901790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 880
Study 31452942 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental denture adhesive (test adhesive) applied with a precision applicator as continuous strips
Number of subjects: 83
Study 31452942 — intervention group
Group type: COMPARATOR
Intervention: Marketed denture adhesive (positive control) applied using a flat ribbon nozzle as dabs
Number of subjects: 83
Study 31452942 — intervention group
Group type: COMPARATOR
Intervention: No adhesive
Number of subjects: 83
Study 29370766 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention with standardized education programme for nursing home staff, implemented over 4 months.
Number of subjects: 765
Study 29370766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing home staff education and communication strategies.
Number of subjects: 765
Study 29370766 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of ACP implementation.
Number of subjects: 765
Study 29370766 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to ACP implementation.
Number of subjects: 765
Study 26708093 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) application
Number of subjects: 60
Study 26708093 — intervention group
Group type: COMPARATOR
Intervention: Placebo KT application
Number of subjects: 60
Study 26708093 — intervention group
Group type: COMPARATOR
Intervention: Control group (without KT application)
Number of subjects: 60
Study 25056233 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-anastomosis gastric bypass (SAGB)
Number of subjects: 0
Study 25056233 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (RYGB)
Number of subjects: 0
Study 22956574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0
Study 22956574 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-CKD)
Number of subjects: 0
Study 19896326 — intervention group
Group type: EXPERIMENTAL
Intervention: THC:CBD extract
Number of subjects: 177
Study 19896326 — intervention group
Group type: EXPERIMENTAL
Intervention: THC extract
Number of subjects: 177
Study 19896326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 17570858 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg per day
Number of subjects: 49
Study 17570858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 15185453 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification with pars plana infusion (Group B)
Number of subjects: 64
Study 15185453 — intervention group
Group type: COMPARATOR
Intervention: Standard phacoemulsification (Group A)
Number of subjects: 64
Study 11480539 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (7.5 mg)
Number of subjects: 5
Study 11480539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 9602871 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol dilution series (range 0.016-250 micrograms/mL)
Number of subjects: 180
Study 9602871 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 2 micrograms/mL citrate-buffered isopropanol solution applied under occlusion for 48 h using small Finn Chambers
Number of subjects: 180
Study 7720502 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Radiotherapy (AR)
Number of subjects: 177
Study 7720502 — intervention group
Group type: COMPARATOR
Intervention: Routine Radiotherapy (RR)
Number of subjects: 177
Study 2810183 — intervention group
Group type: EXPERIMENTAL
Intervention: IV latamoxef disodium
Number of subjects: 229
Study 2810183 — intervention group
Group type: COMPARATOR
Intervention: IV combination of cefuroxime and metronidazole
Number of subjects: 229
Study 2810183 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 229
Study 1106262 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hyperimmune milk globulin (specific protein from hyperimmunized cow colostrum)
Number of subjects: 26
Study 1106262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 31739839 — intervention group
Group type: EXPERIMENTAL
Intervention: Donafenib 200 mg bid
Number of subjects: 27
Study 31739839 — intervention group
Group type: EXPERIMENTAL
Intervention: Donafenib 300 mg bid
Number of subjects: 27
Study 29339585 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure® system
Number of subjects: 20
Study 29339585 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic® system
Number of subjects: 20
Study 25504949 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (supervised, individualized treadmill exercise 2-3 times/week for 9-12 weeks)
Number of subjects: 14
Study 25504949 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 14
Study 25504949 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14
Study 23677137 — intervention group
Group type: EXPERIMENTAL
Intervention: iMics1 NY-60 IOL
Number of subjects: 100
Study 23677137 — intervention group
Group type: COMPARATOR
Intervention: AcrySof SN60WF IOL
Number of subjects: 100
Study 22123473 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% sucrose solution
Number of subjects: 47
Study 22123473 — intervention group
Group type: COMPARATOR
Intervention: Usual care (comfort measures only)
Number of subjects: 47
Study 19955882 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation (2 hours per week for 18 weeks, total of 36 hours)
Number of subjects: 242
Study 19955882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no meditation treatment)
Number of subjects: 242
Study 16881989 — intervention group
Group type: EXPERIMENTAL
Intervention: Doula group
Number of subjects: 600
Study 16881989 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 600
Study 15616119 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.1 mmol/kg)
Number of subjects: 34
Study 15616119 — intervention group
Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine (0.2 mmol/kg)
Number of subjects: 34
Study 11915003 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium avium complex (MAC) prophylaxis
Number of subjects: 643
Study 11915003 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 643
Study 11915003 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadherence to both MAC prophylaxis and antiretroviral therapy
Number of subjects: 643
Study 10091404 — intervention group
Group type: EXPERIMENTAL
Intervention: Gilbert's syndrome (associated with UGT1A (TA)7 variant)
Number of subjects: 102
Study 10091404 — intervention group
Group type: COMPARATOR
Intervention: Control group (neonates without Gilbert's syndrome)
Number of subjects: 102
Study 8527468 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic patients rated low in affective expression
Number of subjects: 58
Study 8527468 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic patients without apparent deficit in affective expression
Number of subjects: 58
Study 8527468 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 58
Study 2161301 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10
Study 2161301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34413 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study 34413 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 0
Study 34413 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 29305407 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume targeting at 4 mL/kg
Number of subjects: 18
Study 29305407 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume targeting at 5 mL/kg
Number of subjects: 18
Study 29305407 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume targeting at 6 mL/kg
Number of subjects: 18
Study 29305407 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume targeting at 7 mL/kg
Number of subjects: 18
Study 28973227 — intervention group
Group type: EXPERIMENTAL
Intervention: Early resuscitation protocol for sepsis (n=107) including intravenous fluid bolus administration, vasopressors targeting mean arterial pressure (≥65 mm Hg), and blood transfusion for hemoglobin <7 g/dL.
Number of subjects: 209
Study 28973227 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=105) determined by treating clinicians.
Number of subjects: 209
Study 28973227 — intervention group
Group type: EXPERIMENTAL
Intervention: Early resuscitation protocol for sepsis (n=107)
Number of subjects: 209
Study 28973227 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=105)
Number of subjects: 209
Study 26294062 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA for 15 min)
Number of subjects: 18
Study 26294062 — intervention group
Group type: COMPARATOR
Intervention: Dual‐hemisphere tDCS (1 mA for 15 min)
Number of subjects: 18
Study 26294062 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (1 mA for 15 min)
Number of subjects: 18
Study 23740688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-wire device
Number of subjects: 22
Study 23740688 — intervention group
Group type: COMPARATOR
Intervention: Shaving (Control)
Number of subjects: 22
Study 23740688 — intervention group
Group type: COMPARATOR
Intervention: Comparison of hot-wire device and shaving
Number of subjects: 22
Study 20829069 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan at 0.05 μg/kg/min
Number of subjects: 41
Study 20829069 — intervention group
Group type: COMPARATOR
Intervention: Milrinone at 0.4 μg/kg/min
Number of subjects: 41
Study 19391532 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Neiguan (PC 6) and Quze (PC 3) combined with routine western medicine
Number of subjects: 32
Study 19391532 — intervention group
Group type: COMPARATOR
Intervention: Routine western medicine
Number of subjects: 32
Study 18035079 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins (LMWHs)
Number of subjects: 27758
Study 18035079 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 27758
Study 15487806 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 0.8 g, 3 times daily for 6 days
Number of subjects: 45
Study 15487806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (ASC) 0.48 g, 3 times daily for 6 days
Number of subjects: 45
Study 15487806 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ASA and ASC
Number of subjects: 45
Study 15487806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ASA or ASC)
Number of subjects: 45
Study 11230785 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT) with conjugated equine estrogen and medroxyprogesterone acetate for 6 months
Number of subjects: 47
Study 11230785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 11230785 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 47
Study 9669827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler (D/A)
Number of subjects: 364
Study 9669827 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily via the Diskhaler (DH)
Number of subjects: 364
Study 8000726 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide and dexamethasone
Number of subjects: 0
Study 8000726 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 0
Study 8000726 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone alone
Number of subjects: 0
Study 8000726 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antiemetic regimens (5‐HT3 antagonist, dexamethasone, benzodiazepine)
Number of subjects: 0
Study 2834929 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (Rohypnol) 0.03 mg/kg body weight
Number of subjects: 0
Study 2834929 — intervention group
Group type: COMPARATOR
Intervention: Pethidine alone
Number of subjects: 0
Study 2834929 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine plus flunitrazepam
Number of subjects: 0
Study 31686093 — intervention group
Group type: EXPERIMENTAL
Intervention: NPT088 treatment for 6 months
Number of subjects: 0